trial · primary record
NTRX-07
Alzheimer Disease
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 48 |
| Primary completion | 2026-03-03 |
| Primary endpoint | Adverse event incidence in NTRX-07 treated participants |
| Registry ID | NCT07058688 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:39.010Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07058688
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.